StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience total assets

Total assets on the balance sheet at the end of each period.

Pure Bioscience's total assets was $1.19M at Jul 31, 2026. For fiscal 2026 it was $1.19M, up 12.8% from the year before. Over ten years it grew -16.9% a year on average. The highest annual figure on record is $7.56M in fiscal 2016.

Annual total assets

PeriodPeriod endValueChange
FY2026Jul 31, 2026$1.19M+12.8%
FY2025Jul 31, 2025$1.06M+29.3%
FY2024Jul 31, 2024$818.00K-55.2%
FY2023Jul 31, 2023$1.83M-59.3%
FY2022Jul 31, 2022$4.48M+4.2%
FY2021Jul 31, 2021$4.30M-31.9%
FY2020Jul 31, 2020$6.32M+227.3%
FY2019Jul 31, 2019$1.93M-25.0%
FY2018Jul 31, 2018$2.58M-32.8%
FY2017Jul 31, 2017$3.83M-49.4%
FY2016Jul 31, 2016$7.56M+131.9%
FY2015Jul 31, 2015$3.26M+75.4%
FY2014Jul 31, 2014$1.86M-9.8%
FY2013Jul 31, 2013$2.06M-53.7%
FY2012Jul 31, 2012$4.46M-13.4%
FY2011Jul 31, 2011$5.15M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026$1.19M+12.8%
Q3 FY2026CQ1 2026Apr 30, 2026$1.56M+47.4%
Q2 FY2026CQ4 2025Jan 31, 2026$788.00K+37.3%
Q1 FY2026CQ3 2025Oct 31, 2025$1.19M+28.4%
Q4 FY2025CQ2 2025Jul 31, 2025$1.06M+29.3%
Q3 FY2025CQ1 2025Apr 30, 2025$1.06M+14.9%
Q2 FY2025CQ4 2024Jan 31, 2025$574.00K-47.1%
Q1 FY2025CQ3 2024Oct 31, 2024$924.00K-58.9%
Q4 FY2024CQ2 2024Jul 31, 2024$818.00K-55.2%
Q3 FY2024CQ1 2024Apr 30, 2024$920.00K-49.6%
Q2 FY2024CQ4 2023Jan 31, 2024$1.09M-57.1%
Q1 FY2024CQ3 2023Oct 31, 2023$2.25M-39.2%
Q4 FY2023CQ2 2023Jul 31, 2023$1.83M-59.3%
Q3 FY2023CQ1 2023Apr 30, 2023$1.82M-13.9%
Q2 FY2023CQ4 2022Jan 31, 2023$2.53M-9.3%
Q1 FY2023CQ3 2022Oct 31, 2022$3.70M+4.1%
Q4 FY2022CQ2 2022Jul 31, 2022$4.48M+4.2%
Q3 FY2022CQ1 2022Apr 30, 2022$2.12M-56.3%
Q2 FY2022CQ4 2021Jan 31, 2022$2.79M-47.2%
Q1 FY2022CQ3 2021Oct 31, 2021$3.56M-38.3%
Q4 FY2021CQ2 2021Jul 31, 2021$4.30M-31.9%
Q3 FY2021CQ1 2021Apr 30, 2021$4.85M+1.3%
Q2 FY2021CQ4 2020Jan 31, 2021$5.29M+260.1%
Q1 FY2021CQ3 2020Oct 31, 2020$5.77M+158.6%
Q4 FY2020CQ2 2020Jul 31, 2020$6.32M+227.3%
Q3 FY2020CQ1 2020Apr 30, 2020$4.79M+179.9%
Q2 FY2020CQ4 2019Jan 31, 2020$1.47M-17.4%
Q1 FY2020CQ3 2019Oct 31, 2019$2.23M-12.2%
Q4 FY2019CQ2 2019Jul 31, 2019$1.93M-25.0%
Q3 FY2019CQ1 2019Apr 30, 2019$1.71M-38.9%
Q2 FY2019CQ4 2018Jan 31, 2019$1.78M-55.3%
Q1 FY2019CQ3 2018Oct 31, 2018$2.54M-51.2%
Q4 FY2018CQ2 2018Jul 31, 2018$2.58M-32.8%
Q3 FY2018CQ1 2018Apr 30, 2018$2.80M-43.0%
Q2 FY2018CQ4 2017Jan 31, 2018$3.97M-35.0%
Q1 FY2018CQ3 2017Oct 31, 2017$5.21M-18.7%
Q4 FY2017CQ2 2017Jul 31, 2017$3.83M–
Q3 FY2017CQ1 2017Apr 30, 2017$4.91M–
Q2 FY2017CQ4 2016Jan 31, 2017$6.11M–
Q1 FY2017CQ3 2016Oct 31, 2016$6.40M–

More Pure Bioscience figures

See a number that looks wrong?